The war in Ukraine has revived worries about nuclear violence. New or improved treatments for radiation poisoning are in the works.
New digital and hybrid approaches to clinical trials are quickly gaining ground. Are they moving too fast?
Is the current spike in highway deaths connected to more widespread cannabis use? Testing obstacles have stood in the way of knowing for sure. That may soon change.
Computer-generated nonsense studies and other fake papers find their way into the scientific literature all too often. A few crusading researchers are fighting back.
Even in his new national advisor role, the former NIH director maintains a pipeline of personal research projects.
Large trials deliver results based on averages, not individuals. The N-of-1 model is a plucky—but labor-intensive—way to right the system.
Proton therapy has been a cutting-edge cancer therapy for decades. Can researchers at last zero in on its best applications?
Medical research labs have faced a difficult stretch of closed buildings and competing priorities. Yet they have also produced milestone discoveries—and not only on COVID-19.
As the first COVID-19 patients arrived, pressure mounted to discover how the disease worked and how it could be beaten back.
Toxic work environments are bad for science. Morteza Mahmoudi is on a crusade to clean them up.